Rockwell Medical, Inc.
RMTI · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 21.4% | 14.8% | 17.6% | – |
| Gross Profit | $0 | $0 | $0 | -$0 |
| % Margin | 17.2% | 10.4% | 5.6% | -3.9% |
| EBITDA | $0 | -$0 | -$0 | -$0 |
| % Margin | 2.9% | -5.6% | -22.2% | -44.9% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -0.5% | -10.1% | -25.7% | -52.8% |
| EPS Diluted | -0.025 | -0.36 | -1.89 | -3.83 |
| % Growth | 93% | 81% | 50.7% | – |
| Operating Cash Flow | $0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | -$0 | -$0 | -$0 |